Logo of jexpmedHomeThe Rockefeller University PressEditorsContactInstructions for AuthorsThis issue
J Exp Med. 1996 Oct 1; 184(4): 1279–1284.
PMCID: PMC2192818

CD5 is a potential selecting ligand for B cell surface immunoglobulin framework region sequences


In rabbits nearly all B lymphocytes express the glycoprotein CD5, in contrast to mice and humans, where only a small proportion of B cells express this molecule (Raman, C., and K.L. Knight. 1992. J. Immunol. 149:3858-3864). CD5+ B cells appear to develop early in ontogeny and be maintained throughout life by self-renewal. The function of CD5 on B cells is still unknown. We showed earlier that "positive" selection occurs during B lymphocyte development in the rabbit appendix. This selection favors B cell expressing surface immunoglobulins with VHa2 structures in the first and third framework regions (Pospisil, R., G.O. Young-Cooper, and R.G. Mage. 1995. Proc. Natl. Acad. Sci. USA. 92:6961- 6965). Here we report that F(ab')2 fragments, especially those bearing VHa2 framework region determinants, specifically interact with the B cell-surface glycoprotein CD5. This interaction can be inhibited by anti-CD5 antibodies. Furthermore, immobilized F(ab')2 fragments selectively bind CD5 molecules in appendix cell lysates. Interactions of VH framework region structures with CD5 may affect maintenance and selective expansion of particular B cells and thus contribute to autostimulatory growth of autoimmune or transformed cells.

Full Text

The Full Text of this article is available as a PDF (950K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Nemazee D, Buerki K. Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras. Proc Natl Acad Sci U S A. 1989 Oct;86(20):8039–8043. [PMC free article] [PubMed]
  • Nemazee DA, Bürki K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature. 1989 Feb 9;337(6207):562–566. [PubMed]
  • Tiegs SL, Russell DM, Nemazee D. Receptor editing in self-reactive bone marrow B cells. J Exp Med. 1993 Apr 1;177(4):1009–1020. [PMC free article] [PubMed]
  • Gay D, Saunders T, Camper S, Weigert M. Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med. 1993 Apr 1;177(4):999–1008. [PMC free article] [PubMed]
  • Nossal GJ. Cellular mechanisms of immunologic tolerance. Annu Rev Immunol. 1983;1:33–62. [PubMed]
  • Goodnow CC. Transgenic mice and analysis of B-cell tolerance. Annu Rev Immunol. 1992;10:489–518. [PubMed]
  • Schwartz RH. Acquisition of immunologic self-tolerance. Cell. 1989 Jun 30;57(7):1073–1081. [PubMed]
  • Pandey A, Tjoelker LW, Thompson CB. Restricted immunoglobulin junctional diversity in neonatal B cells results from developmental selection rather than homology-based V(D)J joining. J Exp Med. 1993 Feb 1;177(2):329–337. [PMC free article] [PubMed]
  • Grandien A, Coutinho A, Andersson J, Freitas AA. Endogenous VH gene family expression in immunoglobulin-transgenic mice: evidence for selection of antibody repertoires. Int Immunol. 1991 Jan;3(1):67–73. [PubMed]
  • Schwartz RS, Stollar BD. Heavy-chain directed B-cell maturation: continuous clonal selection beginning at the pre-B cell stage. Immunol Today. 1994 Jan;15(1):27–32. [PubMed]
  • Zouali M. B-cell superantigens: implications for selection of the human antibody repertoire. Immunol Today. 1995 Aug;16(8):399–405. [PubMed]
  • Knight KL, Becker RS. Molecular basis of the allelic inheritance of rabbit immunoglobulin VH allotypes: implications for the generation of antibody diversity. Cell. 1990 Mar 23;60(6):963–970. [PubMed]
  • Becker RS, Suter M, Knight KL. Restricted utilization of VH and DH genes in leukemic rabbit B cells. Eur J Immunol. 1990 Feb;20(2):397–402. [PubMed]
  • Allegrucci M, Young-Cooper GO, Alexander CB, Newman BA, Mage RG. Preferrential rearrangement in normal rabbits of the 3' VHa allotype gene that is deleted in Alicia mutants; somatic hypermutation/conversion may play a major role in generating the heterogeneity of rabbit heavy chain variable region sequences. Eur J Immunol. 1991 Feb;21(2):411–417. [PubMed]
  • Mage RG, Bernstein KE, McCartney-Francis N, Alexander CB, Young-Cooper GO, Padlan EA, Cohen GH. The structural and genetic basis for expression of normal and latent VHa allotypes of the rabbit. Mol Immunol. 1984 Nov;21(11):1067–1081. [PubMed]
  • Kelus AS, Weiss S. Mutation affecting the expression of immunoglobulin variable regions in the rabbit. Proc Natl Acad Sci U S A. 1986 Jul;83(13):4883–4886. [PMC free article] [PubMed]
  • Pospisil R, Young-Cooper GO, Mage RG. Preferential expansion and survival of B lymphocytes based on VH framework 1 and framework 3 expression: "positive" selection in appendix of normal and VH-mutant rabbits. Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):6961–6965. [PMC free article] [PubMed]
  • Raman C, Knight KL. CD5+ B cells predominate in peripheral tissues of rabbit. J Immunol. 1992 Dec 15;149(12):3858–3864. [PubMed]
  • Abdi HB, Wilder RL, Scher I, Mage RG. Surface immunoglobulin of rabbit peripheral blood lymphocytes: detection of allotypes by fluorescence and rosetting. Eur J Immunol. 1980 Nov;10(11):852–859. [PubMed]
  • Wilder RL, Yuen CC, Mage RG. Preparation and characterization of a heterologous anti-rabbit VH antiserum. Mol Immunol. 1980 Jan;17(1):75–80. [PubMed]
  • Reinherz EL, Kung PC, Goldstein G, Schlossman SF. A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells. J Immunol. 1979 Sep;123(3):1312–1317. [PubMed]
  • Mage RG. Rabbit facts and diversification of VH sequences by gene conversion: comments on "A theory of the ontogeny of the chicken humoral immune system: the consequences of diversification by gene hyperconversion and its extension to rabbit". Res Immunol. 1993 Jul-Sep;144(6-7):476–486. [PubMed]
  • Lankester AC, van Schijndel GM, Cordell JL, van Noesel CJ, van Lier RA. CD5 is associated with the human B cell antigen receptor complex. Eur J Immunol. 1994 Apr;24(4):812–816. [PubMed]
  • Kozlowski LM, Kunning SR, Zheng Y, Wheatley LM, Levinson AI. Staphylococcus aureus Cowan I-induced human immunoglobulin responses: preferential IgM rheumatoid factor production and VH3 mRNA expression by protein A-binding B cells. J Clin Immunol. 1995 May;15(3):145–151. [PubMed]
  • Kipps TJ. The CD5 B cell. Adv Immunol. 1989;47:117–185. [PubMed]
  • Casali P, Notkins AL. CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol Today. 1989 Nov;10(11):364–368. [PubMed]
  • Hardy RR, Carmack CE, Li YS, Hayakawa K. Distinctive developmental origins and specificities of murine CD5+ B cells. Immunol Rev. 1994 Feb;137:91–118. [PubMed]
  • Tarakhovsky A, Kanner SB, Hombach J, Ledbetter JA, Müller W, Killeen N, Rajewsky K. A role for CD5 in TCR-mediated signal transduction and thymocyte selection. Science. 1995 Jul 28;269(5223):535–537. [PubMed]
  • Boumsell L, Bernard A, Lepage V, Degos L, Lemerle J, Dausset J. Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells. Eur J Immunol. 1978 Dec;8(12):900–904. [PubMed]
  • Van de Velde H, von Hoegen I, Luo W, Parnes JR, Thielemans K. The B-cell surface protein CD72/Lyb-2 is the ligand for CD5. Nature. 1991 Jun 20;351(6328):662–665. [PubMed]
  • Chen X, Matsuura Y, Kearney JF. CD5 transgenic mice. Curr Top Microbiol Immunol. 1995;194:209–217. [PubMed]
  • Cyster JG, Healy JI, Kishihara K, Mak TW, Thomas ML, Goodnow CC. Regulation of B-lymphocyte negative and positive selection by tyrosine phosphatase CD45. Nature. 1996 May 23;381(6580):325–328. [PubMed]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press


Save items

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...